Inactive Instrument

Gala Pharmaceutical, Inc.

GLPH

US36316C3043

Solaris Power Cells, Inc. Partners with Gala Global Inc. on Battery-Free Vapor Mod Device

September 18, 2015 at 10:02 am

Solaris Power Cells, Inc. and Gala Global Inc. announced a new marketing partnership. Gala will market and distribute a private labeled model the Solaris high performance vape mode. The Vapor Mod product incorporates Solaris' battery free PESA 'Passive-Electron-Storage-Array' (PESA) storage technology.

Latest news about Gala Pharmaceutical, Inc.

Gala Pharmaceutical, Inc. Announces Executive Changes	21/10/19	CI
Gala Pharmaceutical, Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2019	23/07/19	CI
Gala Pharmaceutical Completes Construction of its Long Beach California Testing Facility	05/06/19	CI
Gala Pharmaceutical, Inc. Reports Earnings Results for the First Quarter Ended February 28, 2019	30/04/19	CI
Gala Pharmaceutical, Inc. Reports Earnings Results for the Full Year Ended November 30, 2018	15/04/19	CI
Gala Pharmaceutical, Inc. Auditor Raises 'Going Concern' Doubt	14/04/19	CI
Gala Pharmaceutical Starts Construction of Its Long Beach California Testing Facility	14/03/19	CI
Gala Pharmaceutical, Inc. Appoints Reiner Hoogenraad as a Member of the Company’s Board of Directors	03/01/19	CI
Gala Pharmaceutical, Inc. Files State License Application for Testing Facility	07/12/18	CI
Gala Pharmaceutical, Inc. Announces Management Changes	30/11/18	CI
Gala Pharmaceutical, Inc. Announces Resignation of Romina Martinez as Director	03/10/18	CI
Gala Pharmaceutical to Form Strategic Alliances with Greengro Technologies and igot420distribution	18/09/18	CI
Gala Pharmaceutical, Inc. Plans to Develop Network of Cannabis Testing Laboratories in an Effort to Capitalize on the Bottleneck Caused by California’S Stringent Cannabis Testing Regulations	28/08/18	CI
Gala Pharmaceutical, Inc. Auditor Raises 'Going Concern' Doubt	05/04/18	CI
Gala Pharmaceutical, Inc. cancelled the acquisition of 51% stake in Cryo Health USA, LLC.	11/02/18	CI
Gala Global Inc. will Change its Name to Gala Pharmaceutical, Inc	10/01/18	CI
Gala Global Inc. will Change its Ticker to GLPH from GLAG	10/01/18	CI
Gala Global Inc. cancelled the acquisition of 80% Controlled Environment Genomics Inc. from Timothy J. Madden.	29/11/17	CI
Gala Global Inc. Announces Management Changes	29/11/17	CI
Gala Global Inc. Names Dr. Maqsood Rehman as COO	16/06/17	CI
Gala Global Inc. announced that it has received $0.26 million in funding from St. George Investments, LLC	31/05/17	CI
Gala Global Inc. announced that it expects to receive $0.26 million in funding from St. George Investments, LLC	14/05/17	CI
Gala Global Inc. Auditor Raises 'Going Concern' Doubt	08/03/17	CI
Gala Global Inc. will Change its Ticker to GLAG from GLAGD	28/02/17	CI
Gala Global Inc. Announces Management Changes	17/02/17	CI

Chart Gala Pharmaceutical, Inc.

Duration

Period

More charts

Company Profile

Gala Pharmaceutical Inc., formerly Gala Global Inc., is engaged in offering plant genomic research, genomic breeding technology, specialty genomic products and laboratory services to agricultural and pharmaceutical sectors. It also provides cGMP (Good Manufacturing Practices) production of active pharmaceutical ingredients (API) for use in clinical trials required to make efficacy claims for varying medical indications. The Company provides operational services and technologies that drive efficiencies in the greenhouse-grown commercial plants and herbs markets.

Sector

Fishing & Farming

More about the company